Hybrid value-based behavioral healthcare provider, Octave, announced it had scored $52 million in Series C funding, bringing its total raise to $86 million.
Cigna Ventures, Novo Holdings and Avidity Partners led the round, with participation from existing investors Greycroft Partners, Health Velocity Capital, Obvious Ventures, Company Ventures and Felicis Ventures.
WHAT IT DOES
Octave offers in...
Australian Pharmaceutical Industries, a wholly-owned subsidiary of ASX-listed conglomerate Wesfarmers, is buying local telehealth business InstantScripts for A$135 million ($91 million).
Founded in 2018, the online health clinic offers a range of digital services, including telehealth consultations, online prescriptions, medical certificates, blood test requests, health management plans and...
As a long-time innovator and Stanford and Harvard-trained physician and scientist, Dr. Daniel Kraft has seen how technological advancements impact patient care and has spoken extensively on the intersection of healthcare and technology.
Kraft, who is also founder and chair of Digital.Health and NextMed Health, and also general partner at Continuum Health Ventures, sat down with MobiHealthNews...
Pomelo Care, a virtual maternity care platform, scored $33 million in seed and Series A funding led by Andreessen Horowitz.
The New York-based company partners with employers, health plans and providers to offer virtual fertility, pregnancy and newborn care from preconception through a baby's first year. Its offerings include nutrition counseling, educational content, primary and women's care,...
Italy-based healthcare agency, consultancy and digital health group, Healthware, and the Digital Therapeutics Alliance, a nonprofit organization based in Virginia that provides thought leadership and education to advance digital therapeutic adoption, today announced the release of a report outlining policy pathways for digital health adoption in Europe.
Alberta Spreafico, managing director of...
Boston-based Laudio, a healthcare management platform, announced that it has raised $13 million in Series B funding, bringing its total raise to $25 million.
Define Ventures led the round, with participation from InHealth Ventures, .406 Ventures, TeleTracking Technologies and MemorialCare Innovation Fund.
A.G Breitenstein, venture partner at Define Ventures, is joining Laudio’s board of directors...
Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
WHAT IT'S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic monitoring technology.
Established in 2017, Nutromics has been developing a "lab-in-a-patch," which uses DNA sensor technology to track multiple targets, such as...
São Paolo-based health tech startup Sami announced it raised $18 million in Series B funding led by Redpoint eventures and Mundi Ventures.
Alumni Ventures, Digital Horizon, Tau Ventures and Endeavor Catalyst also participated in the round alongside current investors Valor Capital, monashees, Kevin Efrusy of Accel, Ricardo Marino of Itaú, Mancora Ventures, Mauro Figueiredo and Brad Otto, a former...
Over two years since it was first acquired, GP2U Telehealth is being sold off again.
Its parent company, UK-based Doctor Care Anywhere Group, signed a share purchase agreement to sell its Australian subsidiary to My Emergency Doctor for A$3 million ($2 million).
The deal, which is still subject to shareholder approval, is expected to be completed by end June.
WHY IT MATTERS
In a media release,...
Tech-enabled sleep health company Nox Health was the highest bidder for Pear Therapeutics' Somryst assets at an auction last month that followed the prescription digital therapeutic company's bankruptcy in April.
Nox bid $3.9 million for Pear's FDA-cleared prescription digital therapeutic Somryst, which uses cognitive behavioral therapy for insomnia to train the brain and body to sleep.
Sigurjon...
b89f.jpg "Sigurjon Kristjansson, CEO of Nox Health")
